Clinical Trial Update: Relapse Prevention With Varenicline [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating relapse prevention with varenicline (Chantix) for smoking cessation; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Substance Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Johns Hopkins University | Conditions: Recurrence, Smoking Cessation | Phase 4 | Status: COMPLETED | Results posted: 2017-06-23